Cargando…
Prognostic Value of a Clinical Biochemistry-Based Nomogram for Coronavirus Disease 2019
Background: This study aimed to explore the predictive value of a clinical biochemistry-based nomogram in COVID-19. Methods: The plasma or serum concentrations/levels of carcinoembryonic antigen (CEA) and other biomarkers, e.g., C-reactive protein (CRP), white blood cell (WBC), interleukin-6 (IL-6),...
Autores principales: | Yu, Jing, Nie, Lei, Wu, Dongde, Chen, Jian, Yang, Zhifeng, Zhang, Ling, Li, Dongqing, Zhou, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848223/ https://www.ncbi.nlm.nih.gov/pubmed/33537326 http://dx.doi.org/10.3389/fmed.2020.597791 |
Ejemplares similares
-
Prognostic value of carcinoembryonic antigen on outcome in patients with coronavirus disease 2019
por: Yu, Jing, et al.
Publicado: (2020) -
Prognostic Value of Clinical Biochemistry-Based Indexes in Nasopharyngeal Carcinoma
por: Zeng, Xiaojiao, et al.
Publicado: (2020) -
Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators
por: Zhang, Jian, et al.
Publicado: (2021) -
Increases prognostic value of clinical-pathological nomogram in patients with esophageal squamous cell carcinoma
por: Hu, Jing Feng, et al.
Publicado: (2023) -
Development and Validation of a Prognostic Nomogram in Lung Cancer With Obstructive Sleep Apnea Syndrome
por: Liu, Wei, et al.
Publicado: (2022)